Bellerophon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(0.0%),Joseph Edelman(0.0%), etc.
Bellerophon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(0.0%),Tang Capital Management, LLC(0.0%), etc.
Bellerophon Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%), etc.
Bellerophon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%), etc.
Bellerophon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%), etc.
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Puissance Capital Management LP
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Amin Naseem
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fernandes Peter
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shah Parag Suresh
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dekker Martin
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bruder Scott P
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kim Bobae
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wang Theodore T
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cloyd Mary Ann
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Teufel Crispin
Bellerophon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(0%),Janus Henderson Biotech Innovation Master Fund Ltd(0%)
Bellerophon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Theodore Wang(10.9%),Puissance Life Science Opportunities Fund VI(10.3%), etc.
Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Puissance Life Science Opportunities Fund VI
Bellerophon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(12.1%),Janus Henderson Biotech Innovation Master Fund Ltd(10.4%)
Bellerophon Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(5.1%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)
No Data